Technology · Biotechnology R&D expenditure
Germany's biotechnology R&D expenditure was 800 M $ in 2026, ranking 6 out of 197. The reported zero reflects budget reallocation: major investments flow through private funds and corporate R&D centers (Bayer, BASF, BioNTech) rather than direct government lines. The country remains a global leader in red biotechnology, especially mRNA vaccines and personalized medicine.
Data for 2026 · unit: $
Position
#6 / 197
Germany world ranking
Country position on the scale from last to first place for this indicator.
DE
#6
#197#1
Trend
Change over time
Change in indicator over the available period.
500 M
1990
1.5 B
2000
3 B
2010
5 B
2020
750 M
2025
800 M
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where Germany stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in Germany — how much?
Based on 2026 data — 800 M $. This is rank #6 out of 197 countries.
What is Germany's rank by Biotechnology R&D expenditure?
Germany ranks #6 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in Germany?
Over the available period the indicator changed from 500 M to 800 M $.